![Thomas Quertermous](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Quertermous
Corporate Officer/Principal chez
Stanford University
Profil
Thomas Quertermous is the founder of VIA Pharmaceuticals, Inc. which was founded in 2004.
He was also the founder of VIA Pharmaceuticals, Inc. in 2004 and held the title of Chief Scientific Officer in 2007.
Currently, he is a Professor at Stanford University since 1997.
He previously worked as a Director at CareDx, Inc. and Aviir, Inc. from 2006 to 2014.
He was also a Director-Cardiology Division & Professor at Vanderbilt University and an Independent Director at BioCardia, Inc. from 2002 to 2019.
Additionally, he was a Principal Laboratory Investigator at The General Hospital Corp.
He received his undergraduate degree from Grinnell College and his graduate and doctorate degrees from The University of Chicago.
Postes actifs de Thomas Quertermous
| Sociétés | Poste | Début |
|---|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1997 |
Anciens postes connus de Thomas Quertermous
| Sociétés | Poste | Fin |
|---|---|---|
| BIOCARDIA, INC. | Directeur/Membre du Conseil | 01/10/2019 |
Aviir, Inc.
 Aviir, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes diagnostic laboratory tests for cardiovascular diseases | Directeur/Membre du Conseil | 16/04/2014 |
VIA Pharmaceuticals, Inc. /Old/
 VIA Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Fondateur | 07/06/2007 |
| VIA PHARMACEUTICALS, INC. | Fondateur | - |
BioCardia, Inc. /Old/
 BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Directeur/Membre du Conseil | - |
Formation de Thomas Quertermous
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
CareDx, Inc.
 CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
VIA Pharmaceuticals, Inc. /Old/
VIA Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Aviir, Inc.
Aviir, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes diagnostic laboratory tests for cardiovascular diseases | Health Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Grinnell College
 Grinnell College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VIA Pharmaceuticals, Inc.
 VIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops compounds for the treatment of cardiovascular and metabolic disease | Health Technology |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Health Technology |
BioCardia, Inc.
 BioCardia, Inc. BiotechnologyHealth Technology Develops biotherapeutics for cardiovascular disease | Health Technology |
Choisissez Zonebourse 
